IXC

Invex Therapeutics Ltd

1 day chart

About IXC

Invex Therapeutics Ltd (IXC) is a biopharmaceutical company focused on the repurposing of an approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke and traumatic brain injury. Invex has trademarked its repurposed Exenatide as Presendin.

Buy Australian shares starting with IXC. Invest today with a CHESS-sponsored broker!

Sector

Health Care

CEO

Industry

Pharmaceuticals

Website

invextherapeutics.com

Market Capitalisation

$35M

Price-earnings ratio

-8.84

Dividend yield

0.00%

High today

$0.46

Low today

$0.43

Open price

$0.46

52-week high

$0.75

52-week low

$0.43

Announcements

IXC FAQs

How much is one share of Invex Therapeutics Ltd?

One share of Invex Therapeutics Ltd is valued at $0.43.

What is the ticker symbol for Invex Therapeutics Ltd?

The ticker symbol for Invex Therapeutics Ltd is IXC.

How do I buy IXC shares in Australia?

To buy IXC stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake AUS
Deposit directly into your Stake wallet and you're ready to invest in IXC

What is the 52-week high for Invex Therapeutics Ltd stock?

The Invex Therapeutics Ltd 52-week high stock price is $0.75.

What is the 52-week low for Invex Therapeutics Ltd stock?

The Invex Therapeutics Ltd 52-week low stock price is $0.43.

What is the market capitalisation of Invex Therapeutics Ltd IXC?

As of 31/03/2023 Invex Therapeutics Ltd has a market cap of $35M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.